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IntrOductIOn 
Irritable Bowel Syndrome (IBS) is the most prevalent dysfunction 
of gastrointestinal tract developed for unknown reasons and 
characterized by gastric pain in defecation and variations in 
bowel habits [1]. By the standard diagnostic criteria of IBS, its 
prevalence depends on numerous variables, but it has been 
reported as ranging 5-20% [2]. IBS affects approximately 7-15% 
of the population in North America, 11.5% in the Europe and 5.8% 
in Iran [2,3]. 
IBS causes a significant economic burden on community through 
reduced work productivity and increased use of health-related 
resources [4] and imposes a large burden on family and community 
so that most patients abandon treatment because of failure to 
afford it. Quality of life in chronic patients is one of the indicators of 
effective healthcare. It is clear that quality of life is influenced by the 
individual’s beliefs, life experiences, personality and expectations. 
Some studies are being done to investigate the effect of quality of 
life on the differences among patients, the prediction of disease, 
and evaluation of interventions [5-10].
IBS affects the patients’ quality of life greatly, so that it occasionally 
disturbs occupational function, traveling and interpersonal 
relationships and prevents the patients from enjoying life [11]. 
Study of the quality of life in the IBS patients for gastrointestinal 
dysfunction is particularly important to determine the rate of recovery 
and therapeutic progress in terms of physical, psychological and 
mental domains because of lack of specific tangible and clinical 
symptoms [12].
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ABStrAct
Introduction: Irritable bowel syndrome (IBS) is one of the most 
prevalent gastroenterological disorders. IBS is characterized 
by abdominal pain, cramping, diarrhea, constipation, bloating 
and flatulence. Complementary therapy is a group of diverse 
therapeutic and health care systems products that are used in 
treatment of IBS. Hypnotherapy helps to alleviate the symptoms 
of a broad range of diseases and conditions. It can be used 
independently or along with other treatments.
Aim: This study was conducted to compare therapeutic effect 
of hypnotherapy plus standard medical treatment and standard 
medical treatment alone on quality of life in patients with IBS.
Materials and Methods: This study is a clinical trial investigating 
60 patients who were enrolled according to Rome-III criteria. The 
sample size was determined per statistical advice, previous studies, 
and the formula of sample size calculation. The participants were 
randomly assigned to two groups of hypnotherapy plus standard 
medical treatment group (n: 30), and standard medical treatment 
group (30). The study consisted of three steps; prior to treatment, 
after treatment and six months after the last intervention (follow-
up). The instruments of data gathering were a questionnaire of 
demographic characteristics and standard questionnaire of 
quality of life for IBS patients (Quality of Life IBS-34). The data 
were analysed by analysis of co-variance, Levene’s test and 
descriptive statistics in SPSS-18.
results: There were significant differences between the two 
groups of study in post-treatment and follow-up stage with 
regards to quality of life (p<0.05).
conclusion: Psychological intervention, particularly hypno-
therapy, alongside standard medical therapy could contribute 
to improving quality of life, pain and fatigue, and psychological 
disorder in IBS patients resistant to treatment. Also, therapeutic 
costs, hospital stay and days lost from work could be decreased 
and patients’ efficiency could be increased.
Hypnosis is a psychotherapeutic approach which helps to 
address or apply the process of hypnotherapy through variations 
in consciousness and a complicated process in the brain with 
three components; concentration, segregation and reduction 
of environmental awareness and empathy [13]. This approach 
was first introduced by Mesmer, a Vienna physician in the 18th 
century, under the theory of animal magnetic and process of 
energy transmission, later known as Mesmerism [14,15]. Hypnosis 
contributes to treatment of gastrointestinal diseases including 
gastric and duodenal ulcers, IBS, Crohn's disease, reflux, bloat, 
nausea, vomiting and abdominal neuralgia [8]. 
Hypnotherapy exerts therapeutic effects on IBS symptoms. Few 
studies have already reported long term effects of hypnotherapy 
[9]. Quality of life and symptoms decreased significantly in 63% 
of the participants after military training [16]. Pain was relieved in 
patients after 7-12 sessions of hypnotherapy [17]. The symptoms 
of IBS changed in follow-up period [18]. Rectal sensitivity was 
reduced after hypnotherapy [15,19]. Hypnotherapy contributed to 
the symptoms management and control [4]. Many studies have 
demonstrated the efficacy of psychological intervention such as 
relaxation, cognitive and behavioral therapy and meditation on 
improvement of quality of life and decrease in the symptoms in IBS 
patients [20,21]. These studies have indicated that psychological 
intervention alongside pharmacologic treatments could help the 
signs improve in IBS patients [18]. Since no similar study has been 
yet conducted in Iran and similar studies have been done mainly 
outside Iran, which is greatly different from Iran in terms of lifestyle 
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[table/Fig-2]: Covariance analysis of quality of life score in post-test.
* p < 0.05 between group 1 group 2
[table/Fig-3]: Covariance analysis of quality of life score in follow-up.
* p < 0.05 between group 1 and group 2.
[table/Fig-1]: Demographic characteristics of the participants in the two groups.




Age (mean) 39.51±11.3 38.04±19.71
Sex Male 7(41.17%) 11(64.7%)
Female 12(70.5%) 14(82.3%)
Marital Status Married 12 (70.5%) 14 (82.35%)
Single 8 (29.5%) 3 (17.65%)
Educational level Primary 8(47.05%) 6(35.3%)
Guidance 6(35.3%) 7(41.17%)
Secondary Diploma 11 (2.88%) 3 (17.46%)
Associate degree 
and BSc/BA
1 (5.88%) 1 (5.88%)
Disease history (year) 8.40±5.75 9.24±5.07
and cultural specifications, such as excessive use of sour, acidic, 
carbonated, and spicy foods with many spices, additives and 
preservatives, lately absorbed foods like red meat, fast food, fat, 
and raw foods such as fruits and vegetables, the present study 
was conducted to compare therapeutic effect of hypnotherapy 
plus standard medical treatment and standard medical treatment 
alone on quality of life in the patients with IBS. 
MAterIAlS And MethOdS
This study was a clinical trial. The patients were enrolled according 
to Rome-III criteria, definite diagnosis of IBS by a gastroenterologist 
per the interview and clinical examination. A sample size determined 
as 60 individuals per statistical advice, previous studies, and the 
formula of sample size calculation. The samples were randomly 
assigned to two groups, 1 (hypnotherapy [n: 30]) and 2 (standard 
medical treatment {n: 30}). The study population consisted of all 
patients with gastrointestinal diseases referring a specialty clinic in 
Shahrekord, southwest Iran. In this study, 13 from group 1 and 13 
from group 2 were excluded for no cooperation, migration, death, 
and severe psychological problems. The inclusion criteria were as 
follows: Meeting diagnostic criteria per Rome-III diagnostic criteria 
by a gastroenterologist; lack of taking psychiatric medicines 
within the last three months; failure to participate in psychological 
intervention within the last six months; and consent to participate 
in the study.
The hypnotherapy used in the present study has been developed 
by Wendy [22]. This method is applied for psychosomatic patients 
and its therapeutic design consists of five sessions, which is 
conducted on the patients within one or two sessions per the 
rate and intensity of the symptoms. The duration of each session 
lasted for 45 to 60 minutes. Hypnotherapy was conducted by 
a hypnotist. The first two sessions included hypnotic induction, 
usually with progressive relaxation and other techniques to 
deepen the hypnotic state, followed by suggestions for general 
self-assurance building, ‘self-image rise’ and improved happiness, 
that were related to the individual. The patient was given an 
audiotape, with content similar to the sessions, for daily use to 
practice autohypnosis. From the third session forwards, bowel 
directed hypnotic suggestions and techniques for normalizing and 
controlling bowel function were also used, including: (1) placing 
their hands on their abdomen and inducing a sense of warmth and 
relieve; and (2) imagery to symbolize the bowel which was then 
altered accordingly to represent normal function. For example, a 
patient with loose bowels might imagine the bowel as a rapidly 
flowing river and change it to a much slower smoothly flowing 
one. The patients were expected to practice these techniques 
daily with a second audiotape containing these bowel directed 
suggestions and to use them independently as necessary to 
relieve symptoms. The techniques were then reinforced and/or 
modified if necessary in following sessions when it was possible to 
include other interventions for any specific issues that triggered or 
exacerbated symptoms [22].
During the implementation of the study, both groups received 
standard medical treatment. The standard treatment included 
routine gastroenterological drugs for IBS patients predominantly 
with diarrhea that was prescribed by a gastroenterologist.
The study consisted of three steps; prior to treatment, after 
treatment and six months after the last intervention (follow-
up). The instruments of data gathering were a questionnaire of 
demographic characteristics and standard questionnaire of quality 
of life for IBS patients (Quality of Life IBS-34). This was firstly 
developed by Drossman and Patrick in 1998 [23] and consists of 
34 items and eight subscales; disphoria, interference with activity, 
body image, health worry, food avoidance, social relation, sexual 
problems and relationship. 
The content validity of the questionnaire was confirmed by European 
and Asian academy. For reliability assessment, the questionnaires 
were simultaneously completed and the correlation coefficient was 
calculated as 0.91 [16]. The patients of both groups were asked 
to complete a validated quality of life questionnaire relating to their 
experiences over the preceding 6-month period. The obtained 
data were analysed by analysis of covariance, Levene’s test and 
descriptive statistics in SPSS 18. The study protocol obtained the 
permission from the ethics committee of the university and was 
registered as IRCT20121026825N2 in Iranian Registry of Clinical 
Trials.
reSultS
The findings indicated that the mean age was 38.04 years in the 
group 1 and 39.51 years in the group 2. In the group 1, 64.7% were 
men and 82.35% married, 41.17% had guidance and secondary 
education and mean history of IBS was derived 9.24 years [Table/
Fig-1]. 
The findings indicated that score of quality of life in the group 1 
increased significantly after the intervention compared to the 
group 2 (p<0.05). Coefficient was obtained 0.44. In other words, 
0.44% of the variance in post-test (quality of life) was related to 
hypnotherapy [Table/Fig-2].
In addition, the findings indicated a significant difference in quality 
of life in IBS patients between group 1 and group 2 in follow-
up (p<0.05). There was no statistically significant difference 
in psychophysical symptoms, abdominal pain, diarrhea and 
pathophysiological signs between the two groups. These findings 
indicated that hypnotherapy improved quality of life in the IBS 
patients [Table/Fig-3]. Further, hypnotherapy reduced somatic, 
mental symptoms, abdominal pain, diarrhea, depression, isolation, 
anxiety and psychopathological symptoms. 
dIScuSSIOn
Mean history of the disease in the present study was obtained 8-9 
years which indicates the chronic nature of IBS. These patients 
Statistical indices
Sources of variation




pretest 180.55 1 0.929 0.343 0.029 0.154
Group membership 4788.12 1 24.63 0.0001 0.44 0.998
Statistical indices
Sources of variation




pretest 139.05 1 1.20 0.282 0.37 0.186
Group membership 866.04 1 7.47 0.01* 0.194 0.754
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suffer from numerous mental disorders and psychological 
problems, so that most of them became depressed and isolated, 
encountered family difficulties, lived an anxious, troubled life, 
underwent pharmacologic treatment alone and paid no attention 
to psychological factors that exacerbated the symptoms within 
the disease. A study indicated that about 50-90% of the IBS 
patients adhering to their treatment reported previous psychiatric 
intervention [24]. Hypnosis can reduce anxiety. It is also effective 
for insomnia, particularly when the techniques are integrated into 
a package of cognitive therapy. Hypnosis enhances the effects 
of cognitive behavioral therapy for conditions such as phobia, 
obesity and anxiety. In the present study, the majority (55%) of 
the participants were male, which is not consistent with Hungin et 
al and Greenberg et al studies that found a higher prevalence of 
IBS in women [14, 25]. One of the reasons for this inconsistency 
could be the small sample size and/or exclusion of many female 
patients with exclusion criteria. Other findings indicated that the 
mean score of quality of life decreased significantly in the patients 
in the group 1 compared to the group 2 after hypnotherapeutic 
intervention. These findings are consistent with Lindfors et 
al., study. The findings demonstrated a significant difference 
between the two groups after the intervention and three months 
after the last intervention (follow-up). In addition, the quality of 
life improved notably in the hypnotherapy group for both quality 
of life and symptoms [18]. In another study, 53% decrease 
was seen in symptoms after six sessions of hypnotherapy 
[26], which is consistent with the present study. Hypnosis can 
sometimes exacerbate the psychological problems, for example 
in the patients with post-traumatic disorders or by inducing 
“false memories” in psychologically susceptible individuals. Its 
use should be avoided in patients with borderline personality 
disorder, dissociative disorders, or the patients who have 
previous profound abuse.
In Vlieger et al., study, hypnotherapy caused a decrease in 
susceptibility, gastric pain and symptoms in IBS patients in case 
group [27]. In another study, hypnotherapy reduced the severity 
of symptoms, improved the quality of life, reduced total scores of 
dissatisfaction and increased the satisfaction in IBS patients [16], 
which confirms the presents study. Wilson et al., Whorwell et al., 
and Hefner et al., have also confirmed the efficacy of this therapy 
on improvement of quality of life and decrease in IBS symptoms 
[4,17,19]. The evidence has shown that the combination of 
hypnotherapy plus standard medical treatment is superior to 
medical treatment alone for IBS treatment.
Other finding of the present study indicated that significant 
difference between the groups 1 and 2 was obtained six months 
after the last intervention (follow-up). This was consistent with 
another study [28]. As described by the biopsychosocial model of 
medicine, modulation of the stress response can result in a change 
in intestinal function and the symptom experience for the patient, 
so hypnotherapy is the most evidence-based psychophysical 
intervention for IBS.
lIMItAtIOn
Small sample size was a limitation of the present study, which 
affects the generalization of the findings. The major barrier to the 
clinical use of hypnotherapy was its limited availability outside of 
the centers especially interested in hypnotherapy for IBS. Further 
study of group hypnotherapy as well as home hypnotherapy (by 
CD or other audio guides) is needed to expand the availability of 
this promising intervention.
cOncluSIOn
Standard treatments of IBS remain unsatisfactory for many patients. 
Use of psychological intervention, particularly hypnotherapy, 
alongside standard medical therapy could contribute to improving 
quality of life in IBS patients resistant to treatment. Therefore, it 
is recommended to have gastroenterologists, psychologists, 
nurses and psychiatrists co-operate in treating IBS patients and 
to develop the treatments as pharmacologic, counseling and 
psychotherapeutic packages.
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